324 related articles for article (PubMed ID: 18254226)
1. [Safety of long-term replacement hormonal therapy in patients with erectile dysfunction and androgen deficiency].
Morgunov LIu; Vertkin AL; Pushkar' DIu
Urologiia; 2007; (5):49-51. PubMed ID: 18254226
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
3. Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone.
Kalinchenko SY; Kozlov GI; Gontcharov NP; Katsiya GV
Aging Male; 2003 Jun; 6(2):94-9. PubMed ID: 12898793
[TBL] [Abstract][Full Text] [Related]
4. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
Boyanov MA; Boneva Z; Christov VG
Aging Male; 2003 Mar; 6(1):1-7. PubMed ID: 12809074
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement.
Gerstenbluth RE; Maniam PN; Corty EW; Seftel AD
J Androl; 2002; 23(6):922-6. PubMed ID: 12399540
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].
Kalinchenko SIu; Vorslov LO; Aglamazian NL; Morgunov LIu
Urologiia; 2007; (1):57, 59-61. PubMed ID: 17472002
[TBL] [Abstract][Full Text] [Related]
7. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.
DiBlasio CJ; Malcolm JB; Derweesh IH; Womack JH; Kincade MC; Mancini JG; Ogles ML; Lamar KD; Patterson AL; Wake RW
BJU Int; 2008 Jul; 102(1):39-43. PubMed ID: 18294309
[TBL] [Abstract][Full Text] [Related]
8. The effect of androgen supplementation therapy on the prostate.
Kaufman JM
Aging Male; 2003 Sep; 6(3):166-74. PubMed ID: 14628497
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer following testosterone replacement in Klinefelter syndrome.
Bydder SA; Joseph DJ; Weinstein S; Stuckey BG
ANZ J Surg; 2007; 77(1-2):93-4. PubMed ID: 17295832
[TBL] [Abstract][Full Text] [Related]
10. The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel.
Ebert T; Jockenhövel F; Morales A; Shabsigh R
Eur Urol; 2005 Feb; 47(2):137-46. PubMed ID: 15661407
[TBL] [Abstract][Full Text] [Related]
11. Monitoring androgen replacement therapy: testosterone and prostate safety.
Morales A
J Endocrinol Invest; 2005; 28(3 Suppl):122-7. PubMed ID: 16042371
[TBL] [Abstract][Full Text] [Related]
12. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging.
Cavallini G; Caracciolo S; Vitali G; Modenini F; Biagiotti G
Urology; 2004 Apr; 63(4):641-6. PubMed ID: 15072869
[TBL] [Abstract][Full Text] [Related]
13. Testosterone therapy in the ageing male: what about the prostate?
Schultheiss D; Machtens S; Jonas U
Andrologia; 2004 Dec; 36(6):355-65. PubMed ID: 15541051
[TBL] [Abstract][Full Text] [Related]
14. Prostatic complications of testosterone replacement therapy.
Jackson JA; Waxman J; Spiekerman AM
Arch Intern Med; 1989 Oct; 149(10):2365-6. PubMed ID: 2679476
[TBL] [Abstract][Full Text] [Related]
15. [Effects of different treatments on endothelial function in patients with erectile dysfunction and hypogonadism].
Mazo EB; Gamidov SI; Sotnikova EM
Ter Arkh; 2008; 80(12):59-63. PubMed ID: 19227909
[TBL] [Abstract][Full Text] [Related]
16. Androgen deficiency in the etiology and treatment of erectile dysfunction.
Gore JL; Swerdloff RS; Rajfer J
Urol Clin North Am; 2005 Nov; 32(4):457-68, vi-vii. PubMed ID: 16291037
[TBL] [Abstract][Full Text] [Related]
17. The relationship between hypogonadism and erectile dysfunction.
Hwang TI; Lin YC
Int J Impot Res; 2008; 20(3):231-5. PubMed ID: 18305486
[TBL] [Abstract][Full Text] [Related]
18. Prostatic specific antigen in patients with hypogonadism: effect of testosterone replacement.
El-Sakka AI; Hassoba HM; Elbakry AM; Hassan HA
J Sex Med; 2005 Mar; 2(2):235-40. PubMed ID: 16422891
[TBL] [Abstract][Full Text] [Related]
19. [65-month testosterone replacement therapy for androgen deficiency-induced ED: a case report and review of the literature].
Jiang T; Zheng L; Sun DC; Li QL; Zhang ZW; Wang FP; Wang QF; Jiang H
Zhonghua Nan Ke Xue; 2014 Feb; 20(2):152-5. PubMed ID: 24520668
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of androgen deficiency in men with erectile dysfunction.
Köhler TS; Kim J; Feia K; Bodie J; Johnson N; Makhlouf A; Monga M
Urology; 2008 Apr; 71(4):693-7. PubMed ID: 18313109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]